Yearend

As previously communicated, Stille AB (publ) will publish the interim report for the second quarter of 2026 at 8:00 CET on July 23, 2026. A web-cast telephone conference will be held at 14:00 CET on the same day.

The 2026 annual general meeting in Stille AB was held on May 7, 2026, in Stockholm. The main resolutions passed at the annual general meeting were as follows. More detailed information about the contents of the resolutions may be obtained from the complete notice of the annual general meeting and the complete proposals, which are available on the company’s website.

Net sales amounted to MSEK 179.1 (129.3), which corresponds to an organic growth of 18.6 percent (26.9 percent in constant currencies) and a total growth of 38.5 percent (46.9 percent in constant currencies).

As previously communicated, Stille AB (publ) will publish the interim report for the first quarter of 2026 at 8:00 CET on April 24, 2026. A web-cast telephone conference will be held at 14:00 CET on the same day.

Stille AB holds its annual general meeting on May 7, 2026, at 14:00 CEST, at Advokatfirman Lindahl’s offices on Smålandsgatan 16, Stockholm, Sweden. Registration starts at 13:30 CEST.

Today, Stille AB publishes the annual report for 2025. The report can be found on the company website www.stille.se.

Net sales amounted to MSEK 174.9 (161.2), an increase of 8.5 percent (negative organic growth of 6.1 percent). The quarter was negatively impacted by the phase-out of non-strategic products in surgical instruments that began in early 2025 (MSEK 5.8) and a negative currency effect (MSEK 9.9). Adjusted for these two factors, underlying organic growth would have amounted to 3.7 percent.

The nominating committee in Stille AB (publ) (“Stille”, or “the Company”) shall consist of three members, who shall represent the three shareholders with the highest number of shares willing to participate in the nominating committee, along with the Chairman of the Board. The nominating committee shall be appointed during the fourth quarter based on the shareholding at the end of the third...

The nominating committee in Stille AB (publ) (“Stille”, or “the Company”) shall consist of three members, who shall represent the three shareholders with the highest number of shares willing to participate in the nominating committee, along with the Chairman of the Board. The nominating committee shall be appointed during the fourth quarter based on the shareholding at the end of the third...

Revenue amounted to 138.8 MSEK (127.9), an increase of 8.5 percent, of which a negative organic growth of 1.9 percent. The quarter was negatively impacted by the phase-out of non-strategic products in surgical instruments that began in early 2025 and a negative currency effect. Adjusted for these two factors, underlying organic growth would have amounted to 7.3 percent.